Discordant functional and inflammatory parameters in multiple sclerosis patients after autologous haematopoietic stem cell transplantation

Abstract

This article describes outcomes in four patients with advanced multiple sclerosis up to two years after autologous haematopoietic stem cell transplantation using a total-body irradiation-based preparative regimen. MRI and C SF analyses demonstrated clear suppression of the inflammatory processes. The results demonstrate however, a dissociation of inflammation parameters and functional disability findings raising questions about optimal future stem cell transplantatio n strategies for this disease.

Keywords

autologous stem cell transplantation functional outcomes multiple sclerosis

Get full access to this article

View all access options for this article.

References

Kozak T , Havrdova E , Pit’ha J , Gregora E , Pytlik R , Maaloufova J et al. Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis . Transplant Proceed 2001; 33: 2179-2181 .

Burt RK , Cohen BA , Russell E , Spero K , Joshi A , Oyama Y et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of intense immune suppression to prevent disease progression in patients with high disability scores . Blood 2003; 102: 2373-2378 .

Fassas A , Anagnostopoulos A , Kazis A , Kapinas K , Sakellari I , Kimiskidis V et al. Autologous stem cell transplantation in progressive multiple sclerosis-an interim analysis of efficacy . J Clin Immunol 2000; 20(1): 24-30 .

Carreras E , Saiz A , Marin P , Martinez C , Rovira M , Villamor N et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year follow-up in 15 patients . Haematologica 2003; 88: 306-314 .

Openshaw H , Lund BT , Kashyap A , Atkinson R , Sniecinski I , Weiner LP et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring . Biol Blood Marrow Transplant 2000; 6: 563-575 .

Mancardi GL , Saccardi R , Filippi M , Gualandi F , Murialdo A , Inglese M et al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS . Neurology 2001; 57: 62-68 .

Karussis DM , Slavin S , Lehmann D , Mizrachi-Koll R , Abramsky O , Ben-Nun A. Prevention of experimental auto-immune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation . J Immunol 1992; 148: 1693-1698 .

van Gelder M , Kinwel-Bohre EP , van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT . Bone Marrow Transplant 1993; 11: 233-241 .

Karussis DM , Slavin S , Ben-Nun A , Ovadia H , Vourka-Karussis U , Lehmann D et al. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation . J Neuroimmunol 1992; 39: 201-210 .

10.

Burt RK , Burns W , Ruvolo P , Fischer A , Shiao C , Guimaraes A et al. Syngeneic bone marrow transplantation eliminates V(beta) 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis . J Neurosci Res 1995; 41: 526-531 .

11.

McAllister LD , Beatty PG , Rose, J. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis . Bone Marrow Transplant 1997; 19: 395-397 .

12.

Tyndall A , Passweg J , Gratwohl A. Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000 . Ann Rheum Dis 2001; 60: 702-707 .

13.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-1452 .

14.

Sipe JC , Knobler RL , Braheny SL , Rice GP , Panitch HS , Oldstone MB. A neurological rating scale (NRS) multiple sclerosis . Neurology 1984; 34: 368-1372 .

15.

Cutter GR , Baier ML , Rudick RA , Cookfair DL , Fischer JS , Petkau J et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure . Brain 1999; 122: 871-882 .

16.

Nash RA , Bowen JD , McSweeney PA , Pavletic SZ , Maravilla KR , Park MS et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis . Blood 2003; 102: 2364-2372 .

17.

Poser CM , Paty DW , Scheinberg L , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13: 227-231 .

18.

Trapp BD , Peterson J , Ransohoff RM , Rudick R , Mork S , Bo L. Axonal transection in the lesions of multiple sclerosis . N Engl J Med 1998; 338: 278-285 .

19.

Tourbah A , Stievenart JL , Gout O , Fontaine B , Liblau R , Lubetzki C et al. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis . Neurology 1999; 53: 1091-1097 .

20.

Fassas A , Passweg JR , Anagnostopoulos A , Kazis A , Kozak T , Havrdova E et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study . J Neurol. 2002; 249(8): 1088-1097 .

21.

Muraro PA , Cassiani Ingoni R , Martin R. Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges . Curr Opin Neurol 2003; 16: 299-305 .

22.

Murphy CB , Hashimoto SA , Graeb D , Thiessen BA. Clinical exacerbation of multiple sclerosis following radiotherapy . Arch Neurol 2003; 60: 273-275 .

23.

Saiz A , Carreras E , Berenguer J , Yague J , Martinez C , Marin et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS . Neurology 2001; 56: 1084-1089 .